News

Measurabl Collaborates with Australian Green Building Leaders

Measurabl Collaborates with Australian Green Building Leaders

Measurabl Partners with Green Building Council of Australia

Measurabl, the foremost sustainability data platform for real estate, has formed a significant partnership with the Green Building Council of Australia (GBCA). This collaboration is set to incorporate Green Star certification data into Measurabl's expansive data product suite.

Enhancing Global Real Estate Data Accessibility

This exciting partnership integrates Green Star, which is akin to the U.S. Green Building Council's LEED certification. With a current reach extending over 22 billion square feet, covering 120,000+ buildings and approximately $3 trillion in assets under management, Measurabl will now provide greater transparency for properties with Green Star certifications.

Understanding Green Star Certification

Green Star evaluates sustainability across various aspects such as design, construction, and operational performance. It covers critical factors including indoor air quality, energy efficiency, water use, and material selection. When integrated into Measurabl's suite, this enhances the platform’s dataset, affording investors superior benchmarking tools, rigorous due diligence, and comprehensive insight into building performance across diverse markets.

A Global Commitment to Sustainability Standards

Currently, Measurabl's certification partners span leading systems—LEED, BREEAM, and CASBEE, in addition to Green Star. This unified approach allows for robust global coverage of sustainability standards. Investors benefit from a more accurate and comparable view of sustainability performance, solidifying Measurabl's mission to create a standardized sustainability data infrastructure that is investment-grade.

The Vision of Measurabl

Maureen Waters, President of Measurabl, expressed excitement about this partnership, highlighting the importance of connecting local certifications to global sustainability objectives and capital flows. This initiative accentuates Measurabl's drive to transform the world’s sustainability data infrastructure and establish a reliable foundation for real estate transactions, from valuations to acquisitions.

The Growth of Green Star

In a remarkable year for Green Star, nearly 1,100 new certifications were added, marking significant growth in Australia’s commitment to sustainable building practices. Currently, 3.4 million Australians frequent shopping centers that boast Green Star certifications, and a considerable portion of office buildings in urban areas are also certified under the Green Star Performance framework.

High-Profile Projects under Green Star

Some notable Green Star-rated projects include the Sydney Swans Headquarters, STARS Hospital in Brisbane, and the Eumemmerring Business Park, reflecting the evolving landscape of sustainable architecture in Australia.

Aligning with Global Climate Goals

As Australia increases its climate ambitions, the GBCA has outlined new emission reduction targets. Jorge Chapa, Chief Impact Officer of GBCA, states, "Buildings are pivotal in fulfilling these commitments. By enhancing the visibility of Green Star on an international platform like Measurabl, we connect climate objectives with tangible assets, reinforcing the value of sustainable buildings for resilience and long-term financial benefits."

Broader Impacts of the Partnership

With the inclusion of Green Star certifications, Measurabl is enhancing global visibility and coverage in sustainability. This initiative also fortifies partnerships with prominent organizations like FTSE Russell, expanding certification data accessibility in Australia and beyond, providing investors with better insights during pre-loan and acquisition evaluations.

Making Sustainability Accessible

This partnership also follows Measurabl's launch of its first free industry-led sustainability solution, which broadens access to the fundamental functionalities of its platform. Within a short timeframe, over 12,000 buildings representing 2.2 billion square feet have joined the platform, emphasizing Measurabl’s commitment to allowing every owner and stakeholder access to crucial sustainability data, regardless of resources or location.

A Leader in Sustainability Data Management

As the leading sustainability data platform for real estate, Measurabl is strategically positioned to shape global standards and integrate sustainability data into every real estate transaction. This partnership represents a significant milestone in their ongoing mission.

Frequently Asked Questions

What is the purpose of the partnership between Measurabl and GBCA?

The partnership aims to integrate Green Star certification data into Measurabl's platform, enhancing sustainability data accessibility for global real estate.

What does Green Star certification assess?

Green Star evaluates sustainability in design, construction, and operations, focusing on factors such as indoor air quality, energy efficiency, water usage, and material selection.

How does this partnership benefit investors?

This partnership provides investors with enhanced benchmarking tools and insights into building performance across various markets, facilitating informed decisions.

What impact has Green Star had in Australia?

Green Star has seen significant growth, with over 3.4 million Australians able to access Green Star-certified shopping centers, signaling a strong commitment to sustainable development.

How many buildings are currently managed by Measurabl?

Measurabl manages more than 22 billion square feet of real estate, highlighting its extensive engagement in the sustainability sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading